New recommendations from the Advisory Committee on Immunization Practices (ACIP), a federal vaccine panel recently reshaped by Health and Human Services Secretary Robert F. Kennedy Jr., have introduced major shifts in U.S. vaccine guidance. The changes mark a departure from long-standing precedent on Covid shots and childhood immunizations and could complicate access in some parts of the country while fueling further public confusion.
At a meeting held in Atlanta last week, ACIP voted to weaken its recommendations for Covid vaccines, rejected the combined measles, mumps, rubella and chickenpox (MMRV) shot for children under 4, and indefinitely delayed a decision on whether to adjust guidance around the hepatitis B vaccine given at birth. The Centers for Disease Control and Prevention still needs to approve the changes, but the agency historically adopts the panel’s recommendations, which directly affect insurance coverage and state-level policies.
While vaccines are not being eliminated, experts warn that the altered guidance adds hurdles. “They didn’t physically take the vaccines away, but they made it more confusing, they made it more bureaucratic, and by doing that, it disincentivizes people from getting vaccinated,” said Dr. Amesh Adalja of the Johns Hopkins Center for Health Security. The risk, he added, is that people who want vaccines may face greater difficulty accessing them.
Some states and regional health networks are attempting to maintain access by issuing their own recommendations that are broader than the federal guidelines. Several state governments have signed directives to preserve Covid vaccine availability, while many major insurers have pledged to keep covering vaccines based on the committee’s previous recommendations. These efforts may help ensure that access remains steady for some patients despite federal changes.
The reshaping of ACIP has raised alarms in the medical community. Kennedy replaced the committee’s members in June, appointing 12 new figures, many of whom have questioned vaccine safety despite decades of evidence to the contrary. During the two-day meeting, concerns about side effects dominated the discussions, reflecting the panel’s new direction.
For now, people seeking clarity are advised to consult their own physicians and rely on vetted medical organizations for updated guidance. Access to Covid vaccines, the MMRV shot, and hepatitis B immunization will likely vary depending on state policies, insurance coverage, and local health providers. The federal changes do not erase availability, but they introduce uncertainty at a time when consistency is critical for public health.
READ MORE: